SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
covid
Journals
4
1
Microbial pathogenesis
2
clinical immunology (orlando, fla)
3
Journal of the American Academy of Dermatology
4
journal of thoracic oncology : official publication of the international association for the study of lung cancer
Research Groups
0
No Research Group Connected
Bibliographies
1305
1
Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids.
2
Use of Systemic Immunomodulatory Therapies During the Coronavirus Disease 2019 (COVID-19) Pandemic.
3
Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment.
4
COVID-19 - Considerations for the paediatric rheumatologist.
5
Early appearance of COVID-19 associated pulmonary infiltrates during daily radiotherapy imaging for lung cancer.
6
COVID-19 or Lung Cancer: what should we treat?
7
In-house responses and anxiety levels of commercial kitchen employees towards new COVID 19 food safety regulations
8
Insight into COVID-2019 for pediatricians.
9
Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.
10
Understanding Unreported Cases in the COVID-19 Epidemic Outbreak in Wuhan, China, and the Importance of Major Public Health Interventions.
11
[A pathological report of three COVID-19 cases by minimally invasive autopsies].
12
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms.
13
Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
14
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
15
COVID-19 - what should anaethesiologists and intensivists know about it?
16
COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation.
17
Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020.
18
Initial Investigation of Transmission of COVID-19 Among Crew Members During Quarantine of a Cruise Ship - Yokohama, Japan, February 2020.
19
WHO Declares COVID-19 a Pandemic.
20
The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks.
21
Artificial Intelligence Distinguishes COVID-19 from Community Acquired Pneumonia on Chest CT.
22
Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study.
23
COVID-2019 and Pregnancy: A plea for transparent reporting of all cases.
24
COVID-19 pandemic: perspectives on an unfolding crisis.
25
Securing the Safety Net and Protecting Public Health During a Pandemic: Medicaid's Response to COVID-19.
26
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.
27
Serial Interval of COVID-19 among Publicly Reported Confirmed Cases.
28
COVID-19: What implications for sexual and reproductive health and rights globally?
29
Should patients stop their biologic treatment during the COVID-19 pandemic.
30
From SARS to COVID-19: A previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans – Call for a One Health approach
31
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
32
Iranian mental health during the COVID-19 epidemic
33
Clinical considerations for patients with diabetes in times of COVID-19 epidemic
34
Traditional Chinese medicine for COVID-19 treatment
35
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
36
Of chloroquine and COVID-19
37
Diabetes and COVID-19
38
How health anxiety influences responses to viral outbreaks like COVID-19: What all decision-makers, health authorities, and health care professionals need to know
39
The coronavirus (COVID-19) epidemic and patient safety
40
A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action
41
Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis
42
Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak
43
World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)
44
The response of Milan's Emergency Medical System to the COVID-19 outbreak in Italy
45
Are high-performing health systems resilient against the COVID-19 epidemic?
46
COVID-19: the gendered impacts of the outbreak
47
Looming threat of COVID-19 infection in Africa: act collectively, and fast
48
Lessons for managing high-consequence infections from first COVID-19 cases in the UK
49
COVID-19 and the anti-lessons of history
50
COVID-19: preparing for superspreader potential among Umrah pilgrims to Saudi Arabia
51
Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study
52
One world, one health: The novel coronavirus COVID-19 epidemic
53
COVID-19: too little, too late?
54
Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19
55
Real-time forecasts of the COVID-19 epidemic in China from February 5th to February 24th, 2020
56
What further should be done to control COVID-19 outbreaks in addition to cases isolation and contact tracing measures?
57
COVID-19 prevention and control recommendations for the ICU
58
Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19)
59
Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China
60
Global spread of COVID-19 and pandemic potential
61
Assessing the Impact of Reduced Travel on Exportation Dynamics of Novel Coronavirus Infection (COVID-19)
62
Going viral – Covid-19 impact assessment: A perspective beyond clinical practice
63
Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients.
64
Transmission potential of the novel coronavirus (COVID-19) onboard the diamond Princess Cruises Ship, 2020.
65
SARS-CoV-2 and COVID-19: The most important research questions.
66
There may be virus in conjunctival secretion of patients with COVID-19.
67
Internationally lost COVID-19 cases.
68
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.
69
Challenges and Countermeasures of Integrative Cancer Therapy in the Epidemic of COVID-19.
70
Undocumented U.S. Immigrants and Covid-19.
71
Artificial Intelligence and Machine Learning to Fight COVID-19.
72
[Follow-up testing of viral nucleic acid in discharged patients with moderate type of 2019 coronavirus disease (COVID-19)].
73
Consensus guidelines for managing the airway in patients with COVID-19.
74
[Dealing with psychological distress by healthcare professionals during the COVID-19 pandemia].
75
Geriatric Care during Public Health Emergencies: Lessons Learned from Novel Corona Virus Disease (COVID-19) Pandemic.
76
The Trial of Chloroquine in the Treatment of Corona Virus Disease 2019 (COVID-19) and Its Research Progress in Forensic Toxicology.
77
Coronavirus (Covid-19) outbreak on the cruise ship Diamond Princess.
78
Novel coronavirus disease (COVID-19) outbreak: Now is the time to refresh pandemic plans.
79
The effectiveness of the quarantine of Wuhan city against the Corona Virus Disease 2019 (COVID-19): well-mixed SEIR model analysis.
80
Positive Externalities of an Epidemic: The Case of the Corona Virus (COVID-19) in China.
81
A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019).
82
The versatile heparin in COVID-19.
83
Response to: Sore throat in COVID-19: comment on "Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis".
84
Vertical Transmission of Coronavirus Disease 19 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review.
85
A case of imported COVID-19 diagnosed by PCR-positive lower respiratory specimen but with PCR-negative throat swabs.
86
Corona Virus (COVID-19) "Infodemic" and Emerging Issues through a Data Lens: The Case of China.
87
A Comparative Study of Chest Computed Tomography Features in Young and Older Adults With Corona Virus Disease (COVID-19).
88
Complex emergencies of COVID-19: management and experience in Zhuhai.
89
Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic.
90
CD-sACE2 Inclusion Compounds: An Effective Treatment for Corona Virus Disease 2019 (COVID-19).
91
Clinical and Transmission Characteristics of Covid-19 - A Retrospective Study of 25 Cases from a Single Thoracic Surgery Department.
92
The COVID-19 Intubation and Ventilation Pathway (CiVP); a Commentary.
93
Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis.
94
Emerging prophylaxis strategies against COVID-19.
95
COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?
96
The different clinical characteristics of corona virus disease cases between children and their families in China - the character of children with COVID-19
97
Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations to follow?
98
Dynamic changes of chest CT imaging in patients with corona virus disease-19 (COVID-19)
99
Management of corona virus disease-19 (COVID-19): the Zhejiang experience
100
[Comparison of two epidemic patterns of COVID-19 and evaluation of prevention and control effectiveness: an analysis based on Guangzhou and Wenzhou].
101
[Epidemiological characteristics of COVID-19 in Shaanxi province].